VERU
VERU INC.
Key Financials
Revenue
$16.9M
↑ 3.6%
Operating Income
$-24750642
↑ 33.0%
Gross Profit
$5.9M
↓ 22.6%
EPS (Diluted)
$-1.10
↓ 4.8%
Total Assets
$29.8M
↓ 50.6%
Shareholders' Equity
$18.3M
↓ 43.3%
Total Liabilities
$11.5M
↓ 59.1%
Cash & Equivalents
$15.8M
↓ 36.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| EFFECT | 4/15/2026 | View on SEC |
| EFFECT | 4/15/2026 | View on SEC |
| S-3 | 4/7/2026 | View on SEC |
| S-3 | 4/7/2026 | View on SEC |
| 8-K | 3/13/2026 | View on SEC |
| SCHEDULE 13G | 2/17/2026 | View on SEC |
| 10-Q | 2/11/2026 | View on SEC |
| 8-K | 2/11/2026 | View on SEC |
| DEFA14A | 1/28/2026 | View on SEC |
| DEF 14A | 1/28/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VERU |
| Company Name | VERU INC. |
| CIK | 863894 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| State of Incorporation | WI |
| Phone | 3125959123 |